We present a 61-year-old male patient who underwent selective TACE for segment VIII hepatocellular carcinoma using one vial (2 ml) of DC Bead LUMI (70-150 µm) loaded with 75 mg of doxorubicin, mixed with 18 ml of nonionic iso-osmolar contrast (Visipaque™ 320). After embolization, contrast retention was observed in the majority of the tumor with a small defect in the inferior margin [ Figure 1 ], which feeder could not be identified. US could not clearly visualize the target residual lesion. Therefore, combined fluoroscopic and US guidance was done for precise positioning of the microwave (MW) antenna (Emprint™, Medtronic, MN, USA) within the nonembolized tumor part [ Figure 2 ]. MW ablation was performed utilizing 100 watts over 2 min.
Follow-up CT scan of the abdomen [ Figure 3 ] after 6 weeks showed successful treatment with no residual enhancement of the treated lesion.
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